N.Y. U.S. Attorney: Leader of Black-Market HIV Medication Fraud Scheme Pleads Guilty
According to the allegations contained in the Superseding Indictments and statements made in court proceedings:
From at least in or about 2017 through at least in or about 2023, AMINOV and others engaged in a scheme that defrauded Medicaid, Medicare, and private insurance companies out of at least approximately
AMINOV distributed black-market HIV medications to pharmacies that were owned and operated by other co-conspirators. That medication was then dispensed to unknowing patients who believed they were receiving legitimate medication. To further their scheme and conceal their proceeds, co-conspirators used bank accounts associated with their respective pharmacies to funnel money to shell companies controlled by AMINOV.
* * *
AMINOV, 47, of
The maximum potential sentence in this case is prescribed by
This case is being handled by the Office's General Crimes Unit. Assistant
* * *
Original text here: https://www.justice.gov/usao-sdny/pr/leader-black-market-hiv-medication-fraud-scheme-pleads-guilty


Health Canada: Making Dental Care More Affordable in Canada
Rocketer and TransUnion Announce Data Collaboration to Maximize High-Quality Customers for Insurance Providers
Advisor News
- A rising retirement challenge: The license to spend
- Financial stress leaves less room for retirement saving
- Giving while you’re living: 3 frequently asked questions about gifting
- Helping clients prepare for one of their biggest retirement expenses
- Important year-end financial conversations every advisor must have
More Advisor NewsAnnuity News
- A rising retirement challenge: The license to spend
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
More Annuity NewsHealth/Employee Benefits News
Life Insurance News